ACTG announces the addition of two monoclonal antibodies to ACTIV-2 outpatient treatment study ...

Retrieved on: 2021-06-09 15:44:47

Tags for this article:

Click the tags to see associated articles and topics

ACTG announces the addition of two monoclonal antibodies to ACTIV-2 outpatient treatment study .... View article details on hiswai:

Excerpt

- The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the addition of two monoclonal antibodies, BMS- ...

Article found on: www.eurekalert.org